Chiral ruthenium(II) complex Δ-[Ru(bpy)2(o-FMPIP)] (bpy = bipyridine, o-FMPIP = 2-(2′-trifluoromethyphenyl) imidazo[4,5-f][1,10]phenanthroline) as potential apoptosis inducer via DNA damage-Reference-Cited by-同舟云学术

Chiral ruthenium(II) complex Δ-[Ru(bpy)2(o-FMPIP)] (bpy = bipyridine, o-FMPIP = 2-(2′-trifluoromethyphenyl) imidazo[4,5-f][1,10]phenanthroline) as potential apoptosis inducer via DNA damage

Published:2019-06 Issue: Volume:853 Page:49-55
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Bai Mingjun,Pan Tao,Yu Gengnan,Xie Qiang,Zeng Zhaolin,Zhang Yanyang,Zhu Duo,Mu Luwen,Qian Jiesheng,Chang Boyang,Mei Wen-Jie,Guan Shouhai

Funder

National Natural Science Foundation of China

Science and Technology Project of Guangdong Province

Innovation Projects in Universities of Guangdong Province

Tradition Chinese Medicine Bureau

Innovation Team Projects

Publisher

Elsevier BV

Subject

Pharmacology

Reference36 articles.

1. Chiral ruthenium(ii) complex as potent radiosensitizer of 125I through DNA-damage-mediated apoptosis;Bai;RSC Adv.,2018

2. Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity;Bergamo;Int. J. Oncol.,2002

3. Metal complex-DNA interactions: from transcription inhibition to photoactivated cleavage;Boerner;Curr. Opin. Chem. Biol.,2005

4. New trends for metal complexes with anticancer activity;Bruijnincx;Curr. Opin. Chem. Biol.,2008

5. Microwave-assisted synthesis of polypyridyl ruthenium(ii) complexes as potential tumor-targeting inhibitors against the migration and invasion of Hela cells through G2/M phase arrest;Cao;RSC Adv.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ru(II) containing photosensitizers for photodynamic therapy: A critique on reporting and an attempt to compare efficacy;Coordination Chemistry Reviews;2022-11

2. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway;Bioorganic Chemistry;2022-02

3. Ru(iii) complexes with pyrazolopyrimidines as anticancer agents: bioactivities and the underlying mechanisms;Dalton Transactions;2022

4. Ruthenium (II) complex cis-[RuII(ŋ2-O2CC7H7O2)(dppm)2]PF6-hmxbato induces ROS-mediated apoptosis in lung tumor cells producing selective cytotoxicity;Scientific Reports;2020-09-21